Desmopressin acetate (DDAVP) is prescribed to a patient for the treatment of diabetes insipidus. The nurse administering the medication monitors the patient for which therapeutic response?
Decreased blood pressure.
Decreased urinary output.
Decreased blood glucose.
Decreased peripheral edema.
The Correct Answer is B
Desmopressin acetate (DDAVP) is a synthetic hormone used to treat diabetes insipidus, which is a condition that causes excessive urination and thirst due to a lack of antidiuretic hormone (ADH) production in the body. By mimicking the effects of ADH, Desmopressin acetate (DDAVP) helps to reduce the amount of urine produced by the body and increase water reabsorption, which helps to alleviate symptoms of diabetes insipidus.
Therefore, the nurse should monitor the patient's urinary output and ensure that it decreases in response to the medication. It is important to note that Desmopressin acetate (DDAVP) can also cause hyponatremia (low sodium levels in the blood), so sodium levels should also be monitored during treatment.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
Diabetic ketoacidosis (DKA) is a serious complication of diabetes that occurs when the body produces high levels of blood acids called ketones. The initial management of DKA involves fluid resuscitation with intravenous normal saline to correct dehydration and electrolyte imbalances. Therefore, starting an infusion of normal saline at 125 ml/hr is the first prescribed action the nurse should implement.
Bringing the patient a meal is not a priority at this time because the patient's blood glucose levels need to be stabilized before they can safely consume food. Administering Lantus insulin IV and giving sodium bicarbonate 50 mEq IV push are also not the first-line treatments for DKA. Lantus insulin is a long-acting insulin used to treat hyperglycemia over an extended period and should not be given intravenously. Sodium bicarbonate may be used to correct acidosis, but it is not the first priority in DKA management.
Correct Answer is D
Explanation
Therefore, the correct option is d. Glyburide is a sulfonylurea medication used to treat type 2 diabetes. It works by stimulating the beta cells in the pancreas to produce and release more insulin, which helps to lower blood glucose levels.
Option A is incorrect because glyburide does not affect glucagon secretion from the pancreas. Glucagon is a hormone that raises blood glucose levels by promoting the breakdown of glycogen in the liver.
Option b is incorrect because glyburide should not be taken if the morning blood glucose level is less than 70 mg/dL, as this may increase the risk of hypoglycemia.
Option c is incorrect because glyburide does not interact with IV contrast media. However, some types of IV contrast media can cause kidney damage in patients with diabetes, and the use of glyburide should be temporarily discontinued if a patient is undergoing a procedure that involves the use of contrast media.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today